Klein, Daniel B.; Tabarrok, Alexander - In: American Journal of Economics and Sociology 67 (2008) 5, pp. 743-775
The amended Food, Drug and Cosmetics Act requires efficacy certification for a drug's initial uses ("on-label"), but does not require certification before physicians may prescribe the drug for subsequent uses ("off-label"). Does it make sense to require FDA efficacy certification for new drugs...
